CLINICAL TRIALS PROFILE FOR ETONOGESTREL

All Clinical Trials for etonogestrel

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00369967 ↗	Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents	Terminated	American College of Obstetricians and Gynecologists	N/A	2007-02-01	We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
NCT00369967 ↗	Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents	Terminated	Bayer	N/A	2007-02-01	We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
NCT00369967 ↗	Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents	Terminated	Virginia Commonwealth University	N/A	2007-02-01	We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
NCT00403793 ↗	Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)	Completed	Bayer	Phase 2	2003-10-01	Male volunteers receive a new hormonal contraceptive consisting of an implant releasing a hormone and hormone injections in order to investigate the suppressive effect on sperm production and reversibility of sperm production after end of treatment.
NCT00403793 ↗	Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)	Completed	Merck Sharp & Dohme Corp.	Phase 2	2003-10-01	Male volunteers receive a new hormonal contraceptive consisting of an implant releasing a hormone and hormone injections in order to investigate the suppressive effect on sperm production and reversibility of sperm production after end of treatment.
NCT00612508 ↗	Hormonal Contraception and Vaginal Health	Completed	Oregon Clinical and Translational Research Institute	N/A	2007-05-01	The purpose of this study is to help determine if the route by which women receive hormonal contraception causes different changes to occur in the lining of the vagina. The investigators plan to compare an oral route (taking birth control pills) with a vaginal route (using a vaginal ring).
NCT00612508 ↗	Hormonal Contraception and Vaginal Health	Completed	Oregon Health and Science University	N/A	2007-05-01	The purpose of this study is to help determine if the route by which women receive hormonal contraception causes different changes to occur in the lining of the vagina. The investigators plan to compare an oral route (taking birth control pills) with a vaginal route (using a vaginal ring).

Clinical Trial Conditions for etonogestrel

Condition Name

Condition Name for etonogestrel
Intervention	Trials
Contraception	34
HIV	5
Bleeding	4
Breakthrough Bleeding	3

Condition MeSH

Condition MeSH for etonogestrel
Intervention	Trials
Hemorrhage	12
Uterine Hemorrhage	8
Dysmenorrhea	4
Metrorrhagia	3

Clinical Trial Locations for etonogestrel

Trials by Country

Trials by Country for etonogestrel
Location	Trials
United States	80
Brazil	8
Peru	3
South Africa	3
Thailand	3

Trials by US State

Trials by US State for etonogestrel
Location	Trials
Colorado	9
Oregon	7
Utah	5
Virginia	5
North Carolina	4

Clinical Trial Progress for etonogestrel

Clinical Trial Phase

Clinical Trial Phase for etonogestrel
Clinical Trial Phase	Trials
Phase 4	32
Phase 3	9
Phase 2/Phase 3	2

Clinical Trial Status

Clinical Trial Status for etonogestrel
Clinical Trial Phase	Trials
Completed	33
Recruiting	12
Not yet recruiting	11

Clinical Trial Sponsors for etonogestrel

Sponsor Name

Sponsor Name for etonogestrel
Sponsor	Trials
Merck Sharp & Dohme Corp.	20
University of Colorado, Denver	7
University of Pittsburgh	6

Sponsor Type

Sponsor Type for etonogestrel
Sponsor	Trials
Other	89
Industry	27
NIH	6